[Hepatic encephalopathy. Physiopathology and treatment].
Perney
P
P
Centre de Recherche Clinique André-Viallet, Hôpital Saint-Luc, Université de Montréal, Québec, Canada.
Pomier-Layrargues
G
G
D000596:Amino Acids / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005442:Flumazenil / Q000627:therapeutic use; D006501:Hepatic Encephalopathy / Q000209:etiology / Q000503:physiopathology* / Q000628:therapy; D006801:Humans; D007792:Lactulose / Q000627:therapeutic use; D008103:Liver Cirrhosis / Q000150:complications*; D011167:Portacaval Shunt, Surgical / Q000009:adverse effects*
D000596:Amino Acids; D000900:Anti-Bacterial Agents; D005442:Flumazenil; D007792:Lactulose
Encéphalopathie hépatique. Physiopathologie et traitement.